The Allergy Economy Is Booming. Families Are Still Paying the Price.

The booming allergy-friendly market offers numerous products and therapies, yet families managing food allergies continue to face significant financial, social, and psychological burdens. This paradox highlights a disconnect between industry growth and consumer relief.

Shira Golan

June 9, 2026 · Updated October 15, 2026 · 6 min read

The market for allergy-friendly food has never been bigger, yet the people it was built to serve are not feeling the relief. Roughly 33 million Americans live with food allergies, and a recent analysis cited in FARE's National Indicator Report on Food Allergy puts the societal cost of the disease at $370.8 billion annually, with an estimated $22,000 per patient per year. Meanwhile, supermarkets are adding dedicated allergen-free sections, plant-based milks line the shelves, and new therapies are moving through development pipelines. The paradox is stark: a growing industry and a growing burden, side by side.

Introduction: The Paradox of the Allergy Economy

Food allergy is a disease of the immune system affecting roughly 1 in 10 American adults and 1 in 13 children, according to FARE, the advocacy and research organization whose National Indicator Report details the prevalence, economic burden, workforce shortages and treatment gaps shaping the field. The commercial response has been substantial. Market analysis describes an influx of gluten-free, dairy-free and nut-free products satisfying a broad spectrum of dietary needs, with retail and food service sectors expanding allergen-free lines and offering clearer labeling.

But the same consumers driving that demand report persistent strain. FARE's consumer research found that 71% of food allergy shoppers spend three to five minutes reading the label of every single food they buy, and regularly have to visit multiple stores to meet their families' needs. One parent quoted in that research described selling belongings and relying on food stamps and WIC just to afford food, noting that food banks are often unusable when allergies are involved. The market has grown around these families; it has not yet absorbed their costs.

A Booming Market: Growth and Innovation

The commercial expansion is real and visible. Beyond dedicated supermarket sections, the product landscape has diversified into everyday staples: plant-based milk alternatives such as almond, soy and oat milk are now widely available, and gluten-free grains and flours like quinoa, rice and sorghum are commonly used in baking and cooking. Market analysts expect demand for allergen-free products to keep rising, driving further innovation and expansion.

Part of that growth comes from people who do not have allergies at all. The allergen-free boom also attracts health-conscious consumers avoiding certain ingredients for lifestyle or dietary-preference reasons, which broadens the customer base and helps justify investment. That dual audience is a commercial strength, but it also means product proliferation is not calibrated to the medical needs of the 33 million Americans whose safety depends on strict avoidance. For them, the question is not whether an oat milk exists, but whether every label can be trusted, every restaurant can accommodate, and every therapy is affordable.

Beyond Finances: Social and Psychological Toll

The burden extends well past the grocery bill. The academic review emphasizes that for families managing food allergies, the role of food in society is complex and juxtaposed against the need to avoid known allergens, lest they risk accidental exposure. That tension plays out at every birthday party, school event and restaurant table. The review calls for appropriate diagnoses by an allergist alongside an allied health team committed to supporting the psychological and nutritional needs of the family, implicitly acknowledging that such support is not standard.

The psychological weight is measurable. Among caregivers, FARE's National Indicator Report cites study findings that 56% reported fears trusting others with their children, and 56% reported fears for their children's safety. Dining out compounds the anxiety: a study reported by SnackSafely.com found that 41% of survey respondents avoided specific restaurants more than half the time due to unclear allergen details, and 11% avoided them nearly every time. Factoring in average per-person spending of $10 to $34 and typical party sizes of two to four, each missed party represents a $78 loss, and the hesitation translates into an estimated $12.6 billion annual revenue leak for American restaurants. The finding highlights that allergy considerations rarely affect just one guest; they dictate the choices of entire dining groups, meaning social exclusion and lost commerce travel together.

The Allergy Economy Paradox: Market Growth vs. Consumer Burden

Placing the two sides of the allergy economy side by side makes the disconnect concrete. The table below juxtaposes indicators of commercial growth with the documented financial and social burdens on consumers, drawing on market analysis, FARE's National Indicator Report and consumer research, an academic review of family burdens, and a restaurant-industry study reported by SnackSafely.com.

Market growth indicators contrasted with consumer burden indicators in the U.S. food allergy economy
Indicator	Side of the Paradox	What the Evidence Shows
Allergen-free product expansion	Market growth	An influx of gluten-free, dairy-free and nut-free products, with retail and food service expanding lines and supermarkets adding dedicated sections, per market analysis.
Everyday staple alternatives	Market growth	Plant-based milks and gluten-free grains and flours are widely available, with demand for allergen-free products expected to rise.
Total U.S. economic burden	Consumer burden	An estimated $370.8 billion annually, per an analysis cited in FARE's National Indicator Report — 15 times the $24.8 billion childhood estimate reported over a decade ago.
Annual cost per patient	Consumer burden	About $22,000 per patient per year, an estimate from FARE's report reflecting adults, inflation and indirect costs such as presenteeism.
Household grocery spending	Consumer burden	Food allergy consumers spend 5% more on groceries, per FARE's consumer research; an academic review finds disproportionately higher food costs overall.
Restaurant revenue loss	Consumer burden	An estimated $12.6 billion annually from allergy-affected diners avoiding restaurants over unclear allergen details, per a study reported by SnackSafely.com.
Caregiver fear	Consumer burden	56% of caregivers report fears trusting others with their children and fears for their children's safety, per a study cited in FARE's report.

Market growth indicators contrasted with consumer burden indicators in the U.S. food allergy economy

Indicator

Side of the Paradox

What the Evidence Shows

Allergen-free product expansion

Market growth

An influx of gluten-free, dairy-free and nut-free products, with retail and food service expanding lines and supermarkets adding dedicated sections, per market analysis.

Everyday staple alternatives

Market growth

Plant-based milks and gluten-free grains and flours are widely available, with demand for allergen-free products expected to rise.

Total U.S. economic burden

Consumer burden

An estimated $370.8 billion annually, per an analysis cited in FARE's National Indicator Report — 15 times the $24.8 billion childhood estimate reported over a decade ago.

Annual cost per patient

Consumer burden

About $22,000 per patient per year, an estimate from FARE's report reflecting adults, inflation and indirect costs such as presenteeism.

Household grocery spending

Consumer burden

Food allergy consumers spend 5% more on groceries, per FARE's consumer research; an academic review finds disproportionately higher food costs overall.

Restaurant revenue loss

Consumer burden

An estimated $12.6 billion annually from allergy-affected diners avoiding restaurants over unclear allergen details, per a study reported by SnackSafely.com.

Caregiver fear

Consumer burden

56% of caregivers report fears trusting others with their children and fears for their children's safety, per a study cited in FARE's report.

The pattern across the rows is the article's central finding: every indicator of commercial expansion is matched by an unresolved cost borne by the same population the market serves. Growth in product variety has not reduced per-patient costs, grocery premiums, dining avoidance or caregiver anxiety.